Red Door Analytics

Sara is a biostatistician with over 15 years of experience in register-based epidemiological research. She joined Red Door Analytics part-time in June 2022 and moved to full-time in February 2024.

Her research focuses on cancer survival and survivorship, and she is an engaged lecturer with a passion for teaching statistics to non-statisticians. She maintains affiliations with the Department of Medicine at Karolinska Institutet, Uppsala University, and Lund University.

Publications

43 publications featuring Sara

Peer-reviewed papers from our full list that Sara has co-authored. Most recent first.

2026

  1. Crowther MJ, Gasparini A, Ekberg S, Felizzi F, Gallagher E, Paracha N. A Framework for the Estimation of Quality-Adjusted Life-Years Using Joint Models of Longitudinal and Survival Data. Medical Decision Making 2026. View → jmqaly →
    Cite
    @article{crowther2026,
      author  = {Crowther, M. J. and Gasparini, A. and Ekberg, S. and Felizzi, F. and Gallagher, E. and Paracha, N.},
      title   = {{A Framework for the Estimation of Quality-Adjusted Life-Years Using Joint Models of Longitudinal and Survival Data}},
      journal = {Medical Decision Making},
      year    = {2026},
      doi     = {10.1177/0272989x261477224}
    }
    
    TY  - JOUR
    AU  - Crowther, M. J.
    AU  - Gasparini, A.
    AU  - Ekberg, S.
    AU  - Felizzi, F.
    AU  - Gallagher, E.
    AU  - Paracha, N.
    TI  - A Framework for the Estimation of Quality-Adjusted Life-Years Using Joint Models of Longitudinal and Survival Data
    JO  - Medical Decision Making
    PY  - 2026
    DO  - 10.1177/0272989x261477224
    UR  - https://doi.org/10.1177/0272989x261477224
    ER  - 
    
  2. Morgans AK, Ekberg S, Boegemann M, Paracha N, Gallagher E, Gasparini A, Crowther MJ, Shore N, Wallis CJD. Associations Between Quality of Life and Disease Progression in Metastatic Hormone-sensitive Prostate Cancer: Insights from ARASENS and ARANOTE Trials. European Urology Oncology 2026. View →
    Cite
    @article{morgans2026,
      author  = {Morgans, A. K. and Ekberg, S. and Boegemann, M. and Paracha, N. and Gallagher, E. and Gasparini, A. and Crowther, M. J. and Shore, N. and Wallis, C. J. D.},
      title   = {{Associations Between Quality of Life and Disease Progression in Metastatic Hormone-sensitive Prostate Cancer: Insights from ARASENS and ARANOTE Trials}},
      journal = {European Urology Oncology},
      year    = {2026},
      doi     = {10.1016/j.euo.2026.03.009}
    }
    
    TY  - JOUR
    AU  - Morgans, A. K.
    AU  - Ekberg, S.
    AU  - Boegemann, M.
    AU  - Paracha, N.
    AU  - Gallagher, E.
    AU  - Gasparini, A.
    AU  - Crowther, M. J.
    AU  - Shore, N.
    AU  - Wallis, C. J. D.
    TI  - Associations Between Quality of Life and Disease Progression in Metastatic Hormone-sensitive Prostate Cancer: Insights from ARASENS and ARANOTE Trials
    JO  - European Urology Oncology
    PY  - 2026
    DO  - 10.1016/j.euo.2026.03.009
    UR  - https://doi.org/10.1016/j.euo.2026.03.009
    ER  - 
    
  3. Kazamia K, Ekberg S, Dietrich CE, Eliasson H, Wahren-Herlenius M, Bergman G. Congenital heart defects: familial recurrence patterns in Sweden. European Heart Journal 2026. View →
    Cite
    @article{kazamia2026,
      author  = {Kazamia, K. and Ekberg, S. and Dietrich, C. E. and Eliasson, H. and Wahren-Herlenius, M. and Bergman, G.},
      title   = {{Congenital heart defects: familial recurrence patterns in Sweden}},
      journal = {European Heart Journal},
      year    = {2026},
      doi     = {10.1093/eurheartj/ehaf1048}
    }
    
    TY  - JOUR
    AU  - Kazamia, K.
    AU  - Ekberg, S.
    AU  - Dietrich, C. E.
    AU  - Eliasson, H.
    AU  - Wahren-Herlenius, M.
    AU  - Bergman, G.
    TI  - Congenital heart defects: familial recurrence patterns in Sweden
    JO  - European Heart Journal
    PY  - 2026
    DO  - 10.1093/eurheartj/ehaf1048
    UR  - https://doi.org/10.1093/eurheartj/ehaf1048
    ER  - 
    
  4. Ekberg S, Glimelius I, Albertsson-Lindblad A, Smedby KE, Jerkeman M, Dietrich CE. Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphoma. International Journal of Cancer 2026;158(7):1836-1845. View →
    Cite
    @article{ekberg2026,
      author  = {Ekberg, S. and Glimelius, I. and Albertsson-Lindblad, A. and Smedby, K. E. and Jerkeman, M. and Dietrich, C. E.},
      title   = {{Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphoma}},
      journal = {International Journal of Cancer},
      year    = {2026},
      volume  = {158},
      number  = {7},
      pages   = {1836--1845},
      doi     = {10.1002/ijc.70220}
    }
    
    TY  - JOUR
    AU  - Ekberg, S.
    AU  - Glimelius, I.
    AU  - Albertsson-Lindblad, A.
    AU  - Smedby, K. E.
    AU  - Jerkeman, M.
    AU  - Dietrich, C. E.
    TI  - Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphoma
    JO  - International Journal of Cancer
    PY  - 2026
    VL  - 158
    IS  - 7
    SP  - 1836
    EP  - 1845
    DO  - 10.1002/ijc.70220
    UR  - https://doi.org/10.1002/ijc.70220
    ER  - 
    
  5. Wallis CJD, Ekberg S, Morgans AK, Boegemann M, Paracha N, Gallagher E, Crowther MJ, Shore N. Association of Deep and Durable Prostate-specific Antigen Responses with Outcomes in Metastatic Hormone-sensitive Prostate Cancer: Insights from ARASENS and ARANOTE Trials. European Urology Oncology 2026;9(2):251-258. View →
    Cite
    @article{wallis2026,
      author  = {Wallis, C. J. D. and Ekberg, S. and Morgans, A. K. and Boegemann, M. and Paracha, N. and Gallagher, E. and Crowther, M. J. and Shore, N.},
      title   = {{Association of Deep and Durable Prostate-specific Antigen Responses with Outcomes in Metastatic Hormone-sensitive Prostate Cancer: Insights from ARASENS and ARANOTE Trials}},
      journal = {European Urology Oncology},
      year    = {2026},
      volume  = {9},
      number  = {2},
      pages   = {251--258},
      doi     = {10.1016/j.euo.2025.03.001}
    }
    
    TY  - JOUR
    AU  - Wallis, C. J. D.
    AU  - Ekberg, S.
    AU  - Morgans, A. K.
    AU  - Boegemann, M.
    AU  - Paracha, N.
    AU  - Gallagher, E.
    AU  - Crowther, M. J.
    AU  - Shore, N.
    TI  - Association of Deep and Durable Prostate-specific Antigen Responses with Outcomes in Metastatic Hormone-sensitive Prostate Cancer: Insights from ARASENS and ARANOTE Trials
    JO  - European Urology Oncology
    PY  - 2026
    VL  - 9
    IS  - 2
    SP  - 251
    EP  - 258
    DO  - 10.1016/j.euo.2025.03.001
    UR  - https://doi.org/10.1016/j.euo.2025.03.001
    ER  - 
    
  6. Abalo KD, Trab T, Baech J, Ekberg S, Pahnke S, Albertsson-Lindblad A, Smedby KE, Jerkeman M, Brown P, Larsen TS, Grønbæk K, El-Galaly TC, Glimelius I. Survival in mantle cell lymphoma patients burdened by a second primary malignancy. Leukemia & Lymphoma 2026;67(4):821-831. View →
    Cite
    @article{abalo2026,
      author  = {Abalo, K. D. and Trab, T. and Baech, J. and Ekberg, S. and Pahnke, S. and Albertsson-Lindblad, A. and Smedby, K. E. and Jerkeman, M. and Brown, P. and Larsen, T. S. and Grønbæk, K. and El-Galaly, T. C. and Glimelius, I.},
      title   = {{Survival in mantle cell lymphoma patients burdened by a second primary malignancy}},
      journal = {Leukemia \& Lymphoma},
      year    = {2026},
      volume  = {67},
      number  = {4},
      pages   = {821--831},
      doi     = {10.1080/10428194.2025.2606211}
    }
    
    TY  - JOUR
    AU  - Abalo, K. D.
    AU  - Trab, T.
    AU  - Baech, J.
    AU  - Ekberg, S.
    AU  - Pahnke, S.
    AU  - Albertsson-Lindblad, A.
    AU  - Smedby, K. E.
    AU  - Jerkeman, M.
    AU  - Brown, P.
    AU  - Larsen, T. S.
    AU  - Grønbæk, K.
    AU  - El-Galaly, T. C.
    AU  - Glimelius, I.
    TI  - Survival in mantle cell lymphoma patients burdened by a second primary malignancy
    JO  - Leukemia & Lymphoma
    PY  - 2026
    VL  - 67
    IS  - 4
    SP  - 821
    EP  - 831
    DO  - 10.1080/10428194.2025.2606211
    UR  - https://doi.org/10.1080/10428194.2025.2606211
    ER  - 
    

2025

  1. Andersen LS, Navarro RB, Ekberg S, et al. Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM study. Leukemia 2025;39(12):2997-3003. View →
    Cite
    @article{andersen2025,
      author  = {Andersen, L. S. and Navarro, R. B. and Ekberg, S. and others},
      title   = {{Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM study}},
      journal = {Leukemia},
      year    = {2025},
      volume  = {39},
      number  = {12},
      pages   = {2997--3003},
      doi     = {10.1038/s41375-025-02762-9}
    }
    
    TY  - JOUR
    AU  - Andersen, L. S.
    AU  - Navarro, R. B.
    AU  - Ekberg, S.
    TI  - Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM study
    JO  - Leukemia
    PY  - 2025
    VL  - 39
    IS  - 12
    SP  - 2997
    EP  - 3003
    DO  - 10.1038/s41375-025-02762-9
    UR  - https://doi.org/10.1038/s41375-025-02762-9
    ER  - 
    
  2. Ivert LU, Ekberg S, Smedby KE, Brauner H. Increased mortality due to lymphoma and infections in patients with mycosis fungoides or Sézary syndrome: A Swedish nationwide, population-based cohort study. British Journal of Dermatology 2025;193(4):781-782. View →
    Cite
    @article{ivert2025,
      author  = {Ivert, L. U. and Ekberg, S. and Smedby, K. E. and Brauner, H.},
      title   = {{Increased mortality due to lymphoma and infections in patients with mycosis fungoides or Sézary syndrome: A Swedish nationwide, population-based cohort study}},
      journal = {British Journal of Dermatology},
      year    = {2025},
      volume  = {193},
      number  = {4},
      pages   = {781--782},
      doi     = {10.1093/bjd/ljaf233}
    }
    
    TY  - JOUR
    AU  - Ivert, L. U.
    AU  - Ekberg, S.
    AU  - Smedby, K. E.
    AU  - Brauner, H.
    TI  - Increased mortality due to lymphoma and infections in patients with mycosis fungoides or Sézary syndrome: A Swedish nationwide, population-based cohort study
    JO  - British Journal of Dermatology
    PY  - 2025
    VL  - 193
    IS  - 4
    SP  - 781
    EP  - 782
    DO  - 10.1093/bjd/ljaf233
    UR  - https://doi.org/10.1093/bjd/ljaf233
    ER  - 
    
  3. Albertsson‐Lindblad A, Ekberg S, Glimelius I, Ellin F, Sonnevi K, Lewerin C, Brandefors L, Smedby KE, Jerkeman M. Limited stage mantle cell lymphoma: A real‐world study of primary treatment and prognosis in Sweden 2006–2018. HemaSphere 2025;9(1):e70080. View →
    Cite
    @article{albertssonlindblad2025,
      author  = {Albertsson‐Lindblad, A. and Ekberg, S. and Glimelius, I. and Ellin, F. and Sonnevi, K. and Lewerin, C. and Brandefors, L. and Smedby, K. E. and Jerkeman, M.},
      title   = {{Limited stage mantle cell lymphoma: A real‐world study of primary treatment and prognosis in Sweden 2006--2018}},
      journal = {HemaSphere},
      year    = {2025},
      volume  = {9},
      number  = {1},
      pages   = {e70080},
      doi     = {10.1002/hem3.70080}
    }
    
    TY  - JOUR
    AU  - Albertsson‐Lindblad, A.
    AU  - Ekberg, S.
    AU  - Glimelius, I.
    AU  - Ellin, F.
    AU  - Sonnevi, K.
    AU  - Lewerin, C.
    AU  - Brandefors, L.
    AU  - Smedby, K. E.
    AU  - Jerkeman, M.
    TI  - Limited stage mantle cell lymphoma: A real‐world study of primary treatment and prognosis in Sweden 2006–2018
    JO  - HemaSphere
    PY  - 2025
    VL  - 9
    IS  - 1
    SP  - e70080
    DO  - 10.1002/hem3.70080
    UR  - https://doi.org/10.1002/hem3.70080
    ER  - 
    

2024

  1. Pahnke S, Abalo KD, Ekberg S, Albertsson-Lindblad A, E. Smedby K, Jerkeman M, Glimelius I. Clinical characteristics and outcomes of 476 mantle cell lymphoma patients aged 80 years and older. Blood Cancer Journal 2024;14(1):222. View →
    Cite
    @article{pahnke2024,
      author  = {Pahnke, S. and Abalo, K. D. and Ekberg, S. and Albertsson-Lindblad, A. and E. Smedby, K. and Jerkeman, M. and Glimelius, I.},
      title   = {{Clinical characteristics and outcomes of 476 mantle cell lymphoma patients aged 80 years and older}},
      journal = {Blood Cancer Journal},
      year    = {2024},
      volume  = {14},
      number  = {1},
      pages   = {222},
      doi     = {10.1038/s41408-024-01204-6}
    }
    
    TY  - JOUR
    AU  - Pahnke, S.
    AU  - Abalo, K. D.
    AU  - Ekberg, S.
    AU  - Albertsson-Lindblad, A.
    AU  - E. Smedby, K.
    AU  - Jerkeman, M.
    AU  - Glimelius, I.
    TI  - Clinical characteristics and outcomes of 476 mantle cell lymphoma patients aged 80 years and older
    JO  - Blood Cancer Journal
    PY  - 2024
    VL  - 14
    IS  - 1
    SP  - 222
    DO  - 10.1038/s41408-024-01204-6
    UR  - https://doi.org/10.1038/s41408-024-01204-6
    ER  - 
    
  2. Forsgren E, Ekberg S, Smedby KE, Nylund P, Sjöblom T, Flogegård M, Sjöström S, Hultdin M, Hallén K, Hellström M, Molin D, Enblad G, Glimelius I. Evaluation of coverage, generalisability and validity of the U‐CAN lymphoma biobank in Sweden: A comparison with nationwide registers. British Journal of Haematology 2024;205(5):1794-1803. View →
    Cite
    @article{forsgren2024,
      author  = {Forsgren, E. and Ekberg, S. and Smedby, K. E. and Nylund, P. and Sjöblom, T. and Flogegård, M. and Sjöström, S. and Hultdin, M. and Hallén, K. and Hellström, M. and Molin, D. and Enblad, G. and Glimelius, I.},
      title   = {{Evaluation of coverage, generalisability and validity of the U‐CAN lymphoma biobank in Sweden: A comparison with nationwide registers}},
      journal = {British Journal of Haematology},
      year    = {2024},
      volume  = {205},
      number  = {5},
      pages   = {1794--1803},
      doi     = {10.1111/bjh.19732}
    }
    
    TY  - JOUR
    AU  - Forsgren, E.
    AU  - Ekberg, S.
    AU  - Smedby, K. E.
    AU  - Nylund, P.
    AU  - Sjöblom, T.
    AU  - Flogegård, M.
    AU  - Sjöström, S.
    AU  - Hultdin, M.
    AU  - Hallén, K.
    AU  - Hellström, M.
    AU  - Molin, D.
    AU  - Enblad, G.
    AU  - Glimelius, I.
    TI  - Evaluation of coverage, generalisability and validity of the U‐CAN lymphoma biobank in Sweden: A comparison with nationwide registers
    JO  - British Journal of Haematology
    PY  - 2024
    VL  - 205
    IS  - 5
    SP  - 1794
    EP  - 1803
    DO  - 10.1111/bjh.19732
    UR  - https://doi.org/10.1111/bjh.19732
    ER  - 
    
  3. Glimelius I, Ekberg S, Ekström Smedby K, Wästerlid T. Stable use of radiotherapy in lymphoma patients over time – A comprehensive national overview of radiotherapy use in Sweden with focus on older patients. Clinical and Translational Radiation Oncology 2024;46:100785. View →
    Cite
    @article{glimelius2024,
      author  = {Glimelius, I. and Ekberg, S. and Ekström Smedby, K. and Wästerlid, T.},
      title   = {{Stable use of radiotherapy in lymphoma patients over time -- A comprehensive national overview of radiotherapy use in Sweden with focus on older patients}},
      journal = {Clinical and Translational Radiation Oncology},
      year    = {2024},
      volume  = {46},
      pages   = {100785},
      doi     = {10.1016/j.ctro.2024.100785}
    }
    
    TY  - JOUR
    AU  - Glimelius, I.
    AU  - Ekberg, S.
    AU  - Ekström Smedby, K.
    AU  - Wästerlid, T.
    TI  - Stable use of radiotherapy in lymphoma patients over time – A comprehensive national overview of radiotherapy use in Sweden with focus on older patients
    JO  - Clinical and Translational Radiation Oncology
    PY  - 2024
    VL  - 46
    SP  - 100785
    DO  - 10.1016/j.ctro.2024.100785
    UR  - https://doi.org/10.1016/j.ctro.2024.100785
    ER  - 
    
  4. Harrysson S, Eloranta S, Ekberg S, Enblad G, Andersson PO, Sonnevi K, Ljungqvist M, Sander B, Jerkeman M, Smedby KE. Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy. Leukemia & Lymphoma 2024;65(4):534-537. View →
    Cite
    @article{harrysson2024,
      author  = {Harrysson, S. and Eloranta, S. and Ekberg, S. and Enblad, G. and Andersson, P. O. and Sonnevi, K. and Ljungqvist, M. and Sander, B. and Jerkeman, M. and Smedby, K. E.},
      title   = {{Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy}},
      journal = {Leukemia \& Lymphoma},
      year    = {2024},
      volume  = {65},
      number  = {4},
      pages   = {534--537},
      doi     = {10.1080/10428194.2023.2296361}
    }
    
    TY  - JOUR
    AU  - Harrysson, S.
    AU  - Eloranta, S.
    AU  - Ekberg, S.
    AU  - Enblad, G.
    AU  - Andersson, P. O.
    AU  - Sonnevi, K.
    AU  - Ljungqvist, M.
    AU  - Sander, B.
    AU  - Jerkeman, M.
    AU  - Smedby, K. E.
    TI  - Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
    JO  - Leukemia & Lymphoma
    PY  - 2024
    VL  - 65
    IS  - 4
    SP  - 534
    EP  - 537
    DO  - 10.1080/10428194.2023.2296361
    UR  - https://doi.org/10.1080/10428194.2023.2296361
    ER  - 
    

2023

  1. Jerkeman M, Ekberg S, Glimelius I, Albertsson-Lindblad A, Entrop JP, Ellin F, Sonnevi K, Lewerin C, Brandefors L, Smedby KE. Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete Project. HemaSphere 2023;7(8):e928. View →
    Cite
    @article{jerkeman2023,
      author  = {Jerkeman, M. and Ekberg, S. and Glimelius, I. and Albertsson-Lindblad, A. and Entrop, J. P. and Ellin, F. and Sonnevi, K. and Lewerin, C. and Brandefors, L. and Smedby, K. E.},
      title   = {{Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete Project}},
      journal = {HemaSphere},
      year    = {2023},
      volume  = {7},
      number  = {8},
      pages   = {e928},
      doi     = {10.1097/HS9.0000000000000928}
    }
    
    TY  - JOUR
    AU  - Jerkeman, M.
    AU  - Ekberg, S.
    AU  - Glimelius, I.
    AU  - Albertsson-Lindblad, A.
    AU  - Entrop, J. P.
    AU  - Ellin, F.
    AU  - Sonnevi, K.
    AU  - Lewerin, C.
    AU  - Brandefors, L.
    AU  - Smedby, K. E.
    TI  - Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete Project
    JO  - HemaSphere
    PY  - 2023
    VL  - 7
    IS  - 8
    SP  - e928
    DO  - 10.1097/HS9.0000000000000928
    UR  - https://doi.org/10.1097/HS9.0000000000000928
    ER  - 
    
  2. Abalo KD, Smedby KE, Ekberg S, Eloranta S, Pahnke S, Albertsson-Lindblad A, Jerkeman M, Glimelius I. Secondary malignancies among mantle cell lymphoma patients. European Journal of Cancer 2023;195:113403. View →
    Cite
    @article{abalo2023,
      author  = {Abalo, K. D. and Smedby, K. E. and Ekberg, S. and Eloranta, S. and Pahnke, S. and Albertsson-Lindblad, A. and Jerkeman, M. and Glimelius, I.},
      title   = {{Secondary malignancies among mantle cell lymphoma patients}},
      journal = {European Journal of Cancer},
      year    = {2023},
      volume  = {195},
      pages   = {113403},
      doi     = {10.1016/j.ejca.2023.113403}
    }
    
    TY  - JOUR
    AU  - Abalo, K. D.
    AU  - Smedby, K. E.
    AU  - Ekberg, S.
    AU  - Eloranta, S.
    AU  - Pahnke, S.
    AU  - Albertsson-Lindblad, A.
    AU  - Jerkeman, M.
    AU  - Glimelius, I.
    TI  - Secondary malignancies among mantle cell lymphoma patients
    JO  - European Journal of Cancer
    PY  - 2023
    VL  - 195
    SP  - 113403
    DO  - 10.1016/j.ejca.2023.113403
    UR  - https://doi.org/10.1016/j.ejca.2023.113403
    ER  - 
    
  3. Weibull CE, Wästerlid T, Engelbrekt Wahlin B, Andersson PO, Ekberg S, Lockmer S, Enblad G, Crowther MJ, Kimby E, Ekström Smedby K. Survival by first-line treatment type and timing of progression among follicular lymphoma patients: A national population-based study in Sweden. HemaSphere 2023;3:e838. View →
    Cite
    @article{weibull2023,
      author  = {Weibull, C. E. and Wästerlid, T. and Engelbrekt Wahlin, B. and Andersson, P. O. and Ekberg, S. and Lockmer, S. and Enblad, G. and Crowther, M. J. and Kimby, E. and Ekström Smedby, K.},
      title   = {{Survival by first-line treatment type and timing of progression among follicular lymphoma patients: A national population-based study in Sweden}},
      journal = {HemaSphere},
      year    = {2023},
      volume  = {3},
      pages   = {e838},
      doi     = {10.21203/rs.3.rs-1650382/v1}
    }
    
    TY  - JOUR
    AU  - Weibull, C. E.
    AU  - Wästerlid, T.
    AU  - Engelbrekt Wahlin, B.
    AU  - Andersson, P. O.
    AU  - Ekberg, S.
    AU  - Lockmer, S.
    AU  - Enblad, G.
    AU  - Crowther, M. J.
    AU  - Kimby, E.
    AU  - Ekström Smedby, K.
    TI  - Survival by first-line treatment type and timing of progression among follicular lymphoma patients: A national population-based study in Sweden
    JO  - HemaSphere
    PY  - 2023
    VL  - 3
    SP  - e838
    DO  - 10.21203/rs.3.rs-1650382/v1
    UR  - https://doi.org/10.21203/rs.3.rs-1650382/v1
    ER  - 
    
  4. Ekberg S, Smedby KE, Albertsson-Lindblad A, Jerkeman M, Weibull CE, Glimelius I. Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation. Blood Advances 2023;7(5):866-874. View →
    Cite
    @article{ekberg2023,
      author  = {Ekberg, S. and Smedby, K. E. and Albertsson-Lindblad, A. and Jerkeman, M. and Weibull, C. E. and Glimelius, I.},
      title   = {{Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation}},
      journal = {Blood Advances},
      year    = {2023},
      volume  = {7},
      number  = {5},
      pages   = {866--874},
      doi     = {10.1182/bloodadvances.2022007241}
    }
    
    TY  - JOUR
    AU  - Ekberg, S.
    AU  - Smedby, K. E.
    AU  - Albertsson-Lindblad, A.
    AU  - Jerkeman, M.
    AU  - Weibull, C. E.
    AU  - Glimelius, I.
    TI  - Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
    JO  - Blood Advances
    PY  - 2023
    VL  - 7
    IS  - 5
    SP  - 866
    EP  - 874
    DO  - 10.1182/bloodadvances.2022007241
    UR  - https://doi.org/10.1182/bloodadvances.2022007241
    ER  - 
    

2022

  1. Ekberg S, Crowther M, Harrysson S, Jerkeman M, Ekström Smedby K, Eloranta S. Patient trajectories after diagnosis of diffuse large B-cell lymphoma—a multistate modelling approach to estimate the chance of lasting remission. British Journal of Cancer 2022;127(9):1642-1649. View →
    Cite
    @article{ekberg2022,
      author  = {Ekberg, S. and Crowther, M. and Harrysson, S. and Jerkeman, M. and Ekström Smedby, K. and Eloranta, S.},
      title   = {{Patient trajectories after diagnosis of diffuse large B-cell lymphoma---a multistate modelling approach to estimate the chance of lasting remission}},
      journal = {British Journal of Cancer},
      year    = {2022},
      volume  = {127},
      number  = {9},
      pages   = {1642--1649},
      doi     = {10.1038/s41416-022-01931-2}
    }
    
    TY  - JOUR
    AU  - Ekberg, S.
    AU  - Crowther, M.
    AU  - Harrysson, S.
    AU  - Jerkeman, M.
    AU  - Ekström Smedby, K.
    AU  - Eloranta, S.
    TI  - Patient trajectories after diagnosis of diffuse large B-cell lymphoma—a multistate modelling approach to estimate the chance of lasting remission
    JO  - British Journal of Cancer
    PY  - 2022
    VL  - 127
    IS  - 9
    SP  - 1642
    EP  - 1649
    DO  - 10.1038/s41416-022-01931-2
    UR  - https://doi.org/10.1038/s41416-022-01931-2
    ER  - 
    
  2. Harrysson S, Eloranta S, Ekberg S, Enblad G, El‐Galaly TC, Sander B, Sonnevi K, Andersson P, Jerkeman M, Smedby KE. Outcomes of relapsed/refractory diffuse large B‐cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line—A population‐based study of 736 patients. British Journal of Haematology 2022;198(2):267-277. View →
    Cite
    @article{harrysson2022,
      author  = {Harrysson, S. and Eloranta, S. and Ekberg, S. and Enblad, G. and El‐Galaly, T. C. and Sander, B. and Sonnevi, K. and Andersson, P. and Jerkeman, M. and Smedby, K. E.},
      title   = {{Outcomes of relapsed/refractory diffuse large B‐cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line---A population‐based study of 736 patients}},
      journal = {British Journal of Haematology},
      year    = {2022},
      volume  = {198},
      number  = {2},
      pages   = {267--277},
      doi     = {10.1111/bjh.18197}
    }
    
    TY  - JOUR
    AU  - Harrysson, S.
    AU  - Eloranta, S.
    AU  - Ekberg, S.
    AU  - Enblad, G.
    AU  - El‐Galaly, T. C.
    AU  - Sander, B.
    AU  - Sonnevi, K.
    AU  - Andersson, P.
    AU  - Jerkeman, M.
    AU  - Smedby, K. E.
    TI  - Outcomes of relapsed/refractory diffuse large B‐cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line—A population‐based study of 736 patients
    JO  - British Journal of Haematology
    PY  - 2022
    VL  - 198
    IS  - 2
    SP  - 267
    EP  - 277
    DO  - 10.1111/bjh.18197
    UR  - https://doi.org/10.1111/bjh.18197
    ER  - 
    

2021

  1. Harrysson S, Eloranta S, Ekberg S, Enblad G, Jerkeman M, Wahlin BE, Andersson PO, Smedby KE. Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden. Blood Cancer Journal 2021;11(1):9. View →
    Cite
    @article{harrysson2021,
      author  = {Harrysson, S. and Eloranta, S. and Ekberg, S. and Enblad, G. and Jerkeman, M. and Wahlin, B. E. and Andersson, P. O. and Smedby, K. E.},
      title   = {{Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden}},
      journal = {Blood Cancer Journal},
      year    = {2021},
      volume  = {11},
      number  = {1},
      pages   = {9},
      doi     = {10.1038/s41408-020-00403-1}
    }
    
    TY  - JOUR
    AU  - Harrysson, S.
    AU  - Eloranta, S.
    AU  - Ekberg, S.
    AU  - Enblad, G.
    AU  - Jerkeman, M.
    AU  - Wahlin, B. E.
    AU  - Andersson, P. O.
    AU  - Smedby, K. E.
    TI  - Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
    JO  - Blood Cancer Journal
    PY  - 2021
    VL  - 11
    IS  - 1
    SP  - 9
    DO  - 10.1038/s41408-020-00403-1
    UR  - https://doi.org/10.1038/s41408-020-00403-1
    ER  - 
    
  2. Ekberg S, Harrysson S, Jernberg T, Szummer K, Andersson P‐, Jerkeman M, Smedby KE, Eloranta S. Myocardial infarction in diffuse large B‐cell lymphoma patients – a population‐based matched cohort study. Journal of Internal Medicine 2021;290(5):1048-1060. View →
    Cite
    @article{ekberg2021,
      author  = {Ekberg, S. and Harrysson, S. and Jernberg, T. and Szummer, K. and {Andersson P‐} and Jerkeman, M. and Smedby, K. E. and Eloranta, S.},
      title   = {{Myocardial infarction in diffuse large B‐cell lymphoma patients -- a population‐based matched cohort study}},
      journal = {Journal of Internal Medicine},
      year    = {2021},
      volume  = {290},
      number  = {5},
      pages   = {1048--1060},
      doi     = {10.1111/joim.13303}
    }
    
    TY  - JOUR
    AU  - Ekberg, S.
    AU  - Harrysson, S.
    AU  - Jernberg, T.
    AU  - Szummer, K.
    AU  - Andersson P‐
    AU  - Jerkeman, M.
    AU  - Smedby, K. E.
    AU  - Eloranta, S.
    TI  - Myocardial infarction in diffuse large B‐cell lymphoma patients – a population‐based matched cohort study
    JO  - Journal of Internal Medicine
    PY  - 2021
    VL  - 290
    IS  - 5
    SP  - 1048
    EP  - 1060
    DO  - 10.1111/joim.13303
    UR  - https://doi.org/10.1111/joim.13303
    ER  - 
    
  3. Brånvall E, Ekberg S, Eloranta S, Wästerlid T, Birmann BM, Smedby KE. Statin use and survival in 16 098 patients with non‐Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era. British Journal of Haematology 2021;195(4):552-560. View →
    Cite
    @article{branvall2021,
      author  = {Brånvall, E. and Ekberg, S. and Eloranta, S. and Wästerlid, T. and Birmann, B. M. and Smedby, K. E.},
      title   = {{Statin use and survival in 16 098 patients with non‐Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era}},
      journal = {British Journal of Haematology},
      year    = {2021},
      volume  = {195},
      number  = {4},
      pages   = {552--560},
      doi     = {10.1111/bjh.17733}
    }
    
    TY  - JOUR
    AU  - Brånvall, E.
    AU  - Ekberg, S.
    AU  - Eloranta, S.
    AU  - Wästerlid, T.
    AU  - Birmann, B. M.
    AU  - Smedby, K. E.
    TI  - Statin use and survival in 16 098 patients with non‐Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era
    JO  - British Journal of Haematology
    PY  - 2021
    VL  - 195
    IS  - 4
    SP  - 552
    EP  - 560
    DO  - 10.1111/bjh.17733
    UR  - https://doi.org/10.1111/bjh.17733
    ER  - 
    

2020

  1. Brånvall E, Ekberg S, Eloranta S, Wästerlid T, Birmann BM, Smedby KE. Statin use is associated with improved survival in multiple myeloma: A Swedish population‐based study of 4315 patients. American Journal of Hematology 2020;95(6):652-661. View →
    Cite
    @article{branvall2020,
      author  = {Brånvall, E. and Ekberg, S. and Eloranta, S. and Wästerlid, T. and Birmann, B. M. and Smedby, K. E.},
      title   = {{Statin use is associated with improved survival in multiple myeloma: A Swedish population‐based study of 4315 patients}},
      journal = {American Journal of Hematology},
      year    = {2020},
      volume  = {95},
      number  = {6},
      pages   = {652--661},
      doi     = {10.1002/ajh.25778}
    }
    
    TY  - JOUR
    AU  - Brånvall, E.
    AU  - Ekberg, S.
    AU  - Eloranta, S.
    AU  - Wästerlid, T.
    AU  - Birmann, B. M.
    AU  - Smedby, K. E.
    TI  - Statin use is associated with improved survival in multiple myeloma: A Swedish population‐based study of 4315 patients
    JO  - American Journal of Hematology
    PY  - 2020
    VL  - 95
    IS  - 6
    SP  - 652
    EP  - 661
    DO  - 10.1002/ajh.25778
    UR  - https://doi.org/10.1002/ajh.25778
    ER  - 
    
  2. Ekberg S, E. Smedby K, Glimelius I, Nilsson‐Ehle H, Goldkuhl C, Lewerin C, Jerkeman M, Eloranta S. Trends in the prevalence, incidence and survival of non‐Hodgkin lymphoma subtypes during the 21st century – a Swedish lymphoma register study. British Journal of Haematology 2020;189(6):1083-1092. View →
    Cite
    @article{ekberg2020,
      author  = {Ekberg, S. and E. Smedby, K. and Glimelius, I. and Nilsson‐Ehle, H. and Goldkuhl, C. and Lewerin, C. and Jerkeman, M. and Eloranta, S.},
      title   = {{Trends in the prevalence, incidence and survival of non‐Hodgkin lymphoma subtypes during the 21st century -- a Swedish lymphoma register study}},
      journal = {British Journal of Haematology},
      year    = {2020},
      volume  = {189},
      number  = {6},
      pages   = {1083--1092},
      doi     = {10.1111/bjh.16489}
    }
    
    TY  - JOUR
    AU  - Ekberg, S.
    AU  - E. Smedby, K.
    AU  - Glimelius, I.
    AU  - Nilsson‐Ehle, H.
    AU  - Goldkuhl, C.
    AU  - Lewerin, C.
    AU  - Jerkeman, M.
    AU  - Eloranta, S.
    TI  - Trends in the prevalence, incidence and survival of non‐Hodgkin lymphoma subtypes during the 21st century – a Swedish lymphoma register study
    JO  - British Journal of Haematology
    PY  - 2020
    VL  - 189
    IS  - 6
    SP  - 1083
    EP  - 1092
    DO  - 10.1111/bjh.16489
    UR  - https://doi.org/10.1111/bjh.16489
    ER  - 
    
  3. Rodriguez-Wallberg KA, Lundberg FE, Ekberg S, Johansson ALV, Ludvigsson JF, Almqvist C, Cnattingius S, Iliadou AN. Mortality from infancy to adolescence in singleton children conceived from assisted reproductive techniques versus naturally conceived singletons in Sweden. Fertility and Sterility 2020;113(3):524-532. View →
    Cite
    @article{rodriguezwallberg2020,
      author  = {Rodriguez-Wallberg, K. A. and Lundberg, F. E. and Ekberg, S. and Johansson, A. L. V. and Ludvigsson, J. F. and Almqvist, C. and Cnattingius, S. and Iliadou, A. N.},
      title   = {{Mortality from infancy to adolescence in singleton children conceived from assisted reproductive techniques versus naturally conceived singletons in Sweden}},
      journal = {Fertility and Sterility},
      year    = {2020},
      volume  = {113},
      number  = {3},
      pages   = {524--532},
      doi     = {10.1016/j.fertnstert.2019.10.018}
    }
    
    TY  - JOUR
    AU  - Rodriguez-Wallberg, K. A.
    AU  - Lundberg, F. E.
    AU  - Ekberg, S.
    AU  - Johansson, A. L. V.
    AU  - Ludvigsson, J. F.
    AU  - Almqvist, C.
    AU  - Cnattingius, S.
    AU  - Iliadou, A. N.
    TI  - Mortality from infancy to adolescence in singleton children conceived from assisted reproductive techniques versus naturally conceived singletons in Sweden
    JO  - Fertility and Sterility
    PY  - 2020
    VL  - 113
    IS  - 3
    SP  - 524
    EP  - 532
    DO  - 10.1016/j.fertnstert.2019.10.018
    UR  - https://doi.org/10.1016/j.fertnstert.2019.10.018
    ER  - 
    
  4. Wästerlid T, Harrysson S, Andersson TM‐, Ekberg S, Enblad G, Andersson P, Jerkeman M, Eloranta S, Smedby KE. Outcome and determinants of failure to complete primary R‐CHOP treatment for reasons other than non‐response among patients with diffuse large B‐cell lymphoma. American Journal of Hematology 2020;95(7):740-748. View →
    Cite
    @article{wasterlid2020,
      author  = {Wästerlid, T. and Harrysson, S. and {Andersson TM‐} and Ekberg, S. and Enblad, G. and Andersson, P. and Jerkeman, M. and Eloranta, S. and Smedby, K. E.},
      title   = {{Outcome and determinants of failure to complete primary R‐CHOP treatment for reasons other than non‐response among patients with diffuse large B‐cell lymphoma}},
      journal = {American Journal of Hematology},
      year    = {2020},
      volume  = {95},
      number  = {7},
      pages   = {740--748},
      doi     = {10.1002/ajh.25789}
    }
    
    TY  - JOUR
    AU  - Wästerlid, T.
    AU  - Harrysson, S.
    AU  - Andersson TM‐
    AU  - Ekberg, S.
    AU  - Enblad, G.
    AU  - Andersson, P.
    AU  - Jerkeman, M.
    AU  - Eloranta, S.
    AU  - Smedby, K. E.
    TI  - Outcome and determinants of failure to complete primary R‐CHOP treatment for reasons other than non‐response among patients with diffuse large B‐cell lymphoma
    JO  - American Journal of Hematology
    PY  - 2020
    VL  - 95
    IS  - 7
    SP  - 740
    EP  - 748
    DO  - 10.1002/ajh.25789
    UR  - https://doi.org/10.1002/ajh.25789
    ER  - 
    
  5. Baecklund F, Ekberg S, Rosenquist R, Askling J, Eloranta S, Smedby KE. Concordance in survival among first‐degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia. European Journal of Haematology 2020;105(6):779-785. View →
    Cite
    @article{baecklund2020,
      author  = {Baecklund, F. and Ekberg, S. and Rosenquist, R. and Askling, J. and Eloranta, S. and Smedby, K. E.},
      title   = {{Concordance in survival among first‐degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia}},
      journal = {European Journal of Haematology},
      year    = {2020},
      volume  = {105},
      number  = {6},
      pages   = {779--785},
      doi     = {10.1111/ejh.13510}
    }
    
    TY  - JOUR
    AU  - Baecklund, F.
    AU  - Ekberg, S.
    AU  - Rosenquist, R.
    AU  - Askling, J.
    AU  - Eloranta, S.
    AU  - Smedby, K. E.
    TI  - Concordance in survival among first‐degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia
    JO  - European Journal of Haematology
    PY  - 2020
    VL  - 105
    IS  - 6
    SP  - 779
    EP  - 785
    DO  - 10.1111/ejh.13510
    UR  - https://doi.org/10.1111/ejh.13510
    ER  - 
    
  6. Almqvist C, Ekberg S, Rhedin S, Fang F, Fall T, Lundholm C. Season of birth, childhood asthma and allergy in a nationwide cohort—Mediation through lower respiratory infections. Clinical & Experimental Allergy 2020;50(2):222-230. View →
    Cite
    @article{almqvist2020,
      author  = {Almqvist, C. and Ekberg, S. and Rhedin, S. and Fang, F. and Fall, T. and Lundholm, C.},
      title   = {{Season of birth, childhood asthma and allergy in a nationwide cohort---Mediation through lower respiratory infections}},
      journal = {Clinical \& Experimental Allergy},
      year    = {2020},
      volume  = {50},
      number  = {2},
      pages   = {222--230},
      doi     = {10.1111/cea.13542}
    }
    
    TY  - JOUR
    AU  - Almqvist, C.
    AU  - Ekberg, S.
    AU  - Rhedin, S.
    AU  - Fang, F.
    AU  - Fall, T.
    AU  - Lundholm, C.
    TI  - Season of birth, childhood asthma and allergy in a nationwide cohort—Mediation through lower respiratory infections
    JO  - Clinical & Experimental Allergy
    PY  - 2020
    VL  - 50
    IS  - 2
    SP  - 222
    EP  - 230
    DO  - 10.1111/cea.13542
    UR  - https://doi.org/10.1111/cea.13542
    ER  - 
    

2019

  1. Dahlén E, Ekberg S, Lundholm C, Jonsson EW, Kull I, Wettermark B, Almqvist C. Sibship and dispensing patterns of asthma medication in young children—a population‐based study. Pharmacoepidemiology and Drug Safety 2019;28(8):1109-1116. View →
    Cite
    @article{dahlen2019,
      author  = {Dahlén, E. and Ekberg, S. and Lundholm, C. and Jonsson, E. W. and Kull, I. and Wettermark, B. and Almqvist, C.},
      title   = {{Sibship and dispensing patterns of asthma medication in young children---a population‐based study}},
      journal = {Pharmacoepidemiology and Drug Safety},
      year    = {2019},
      volume  = {28},
      number  = {8},
      pages   = {1109--1116},
      doi     = {10.1002/pds.4802}
    }
    
    TY  - JOUR
    AU  - Dahlén, E.
    AU  - Ekberg, S.
    AU  - Lundholm, C.
    AU  - Jonsson, E. W.
    AU  - Kull, I.
    AU  - Wettermark, B.
    AU  - Almqvist, C.
    TI  - Sibship and dispensing patterns of asthma medication in young children—a population‐based study
    JO  - Pharmacoepidemiology and Drug Safety
    PY  - 2019
    VL  - 28
    IS  - 8
    SP  - 1109
    EP  - 1116
    DO  - 10.1002/pds.4802
    UR  - https://doi.org/10.1002/pds.4802
    ER  - 
    

2018

  1. Frisk G, Ekberg S, Lidbrink E, Eloranta S, Sund M, Fredriksson I, Lambe M, Smedby KE. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study. Breast Cancer Research 2018;20(1):142. View →
    Cite
    @article{frisk2018,
      author  = {Frisk, G. and Ekberg, S. and Lidbrink, E. and Eloranta, S. and Sund, M. and Fredriksson, I. and Lambe, M. and Smedby, K. E.},
      title   = {{No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study}},
      journal = {Breast Cancer Research},
      year    = {2018},
      volume  = {20},
      number  = {1},
      pages   = {142},
      doi     = {10.1186/s13058-018-1065-0}
    }
    
    TY  - JOUR
    AU  - Frisk, G.
    AU  - Ekberg, S.
    AU  - Lidbrink, E.
    AU  - Eloranta, S.
    AU  - Sund, M.
    AU  - Fredriksson, I.
    AU  - Lambe, M.
    AU  - Smedby, K. E.
    TI  - No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study
    JO  - Breast Cancer Research
    PY  - 2018
    VL  - 20
    IS  - 1
    SP  - 142
    DO  - 10.1186/s13058-018-1065-0
    UR  - https://doi.org/10.1186/s13058-018-1065-0
    ER  - 
    
  2. Ekberg S, Jerkeman M, Andersson P, Enblad G, Wahlin BE, Hasselblom S, Andersson TM, Eloranta S, Smedby KE. Long‐term survival and loss in expectancy of life in a population‐based cohort of 7114 patients with diffuse large B‐cell lymphoma. American Journal of Hematology 2018;93(8):1020-1028. View →
    Cite
    @article{ekberg2018,
      author  = {Ekberg, S. and Jerkeman, M. and Andersson, P. and Enblad, G. and Wahlin, B. E. and Hasselblom, S. and Andersson, T. M. and Eloranta, S. and Smedby, K. E.},
      title   = {{Long‐term survival and loss in expectancy of life in a population‐based cohort of 7114 patients with diffuse large B‐cell lymphoma}},
      journal = {American Journal of Hematology},
      year    = {2018},
      volume  = {93},
      number  = {8},
      pages   = {1020--1028},
      doi     = {10.1002/ajh.25147}
    }
    
    TY  - JOUR
    AU  - Ekberg, S.
    AU  - Jerkeman, M.
    AU  - Andersson, P.
    AU  - Enblad, G.
    AU  - Wahlin, B. E.
    AU  - Hasselblom, S.
    AU  - Andersson, T. M.
    AU  - Eloranta, S.
    AU  - Smedby, K. E.
    TI  - Long‐term survival and loss in expectancy of life in a population‐based cohort of 7114 patients with diffuse large B‐cell lymphoma
    JO  - American Journal of Hematology
    PY  - 2018
    VL  - 93
    IS  - 8
    SP  - 1020
    EP  - 1028
    DO  - 10.1002/ajh.25147
    UR  - https://doi.org/10.1002/ajh.25147
    ER  - 
    
  3. Fall T, Ekberg S, Lundholm C, Fang F, Almqvist C. Dog characteristics and future risk of asthma in children growing up with dogs. Scientific Reports 2018;8(1):16899. View →
    Cite
    @article{fall2018,
      author  = {Fall, T. and Ekberg, S. and Lundholm, C. and Fang, F. and Almqvist, C.},
      title   = {{Dog characteristics and future risk of asthma in children growing up with dogs}},
      journal = {Scientific Reports},
      year    = {2018},
      volume  = {8},
      number  = {1},
      pages   = {16899},
      doi     = {10.1038/s41598-018-35245-2}
    }
    
    TY  - JOUR
    AU  - Fall, T.
    AU  - Ekberg, S.
    AU  - Lundholm, C.
    AU  - Fang, F.
    AU  - Almqvist, C.
    TI  - Dog characteristics and future risk of asthma in children growing up with dogs
    JO  - Scientific Reports
    PY  - 2018
    VL  - 8
    IS  - 1
    SP  - 16899
    DO  - 10.1038/s41598-018-35245-2
    UR  - https://doi.org/10.1038/s41598-018-35245-2
    ER  - 
    
  4. Rodriguez-Wallberg KA, Ekberg S, Johansson AL, Iliadou AN. A population-based register study of infant and late child mortality in singletons born after assisted reproductive techniques (ART) vs natural conceptions. Fertility and Sterility 2018;110(4):e12. View →
    Cite
    @article{rodriguezwallberg2018,
      author  = {Rodriguez-Wallberg, K. A. and Ekberg, S. and Johansson, A. L. and Iliadou, A. N.},
      title   = {{A population-based register study of infant and late child mortality in singletons born after assisted reproductive techniques (ART) vs natural conceptions}},
      journal = {Fertility and Sterility},
      year    = {2018},
      volume  = {110},
      number  = {4},
      pages   = {e12},
      doi     = {10.1016/j.fertnstert.2018.07.051}
    }
    
    TY  - JOUR
    AU  - Rodriguez-Wallberg, K. A.
    AU  - Ekberg, S.
    AU  - Johansson, A. L.
    AU  - Iliadou, A. N.
    TI  - A population-based register study of infant and late child mortality in singletons born after assisted reproductive techniques (ART) vs natural conceptions
    JO  - Fertility and Sterility
    PY  - 2018
    VL  - 110
    IS  - 4
    SP  - e12
    DO  - 10.1016/j.fertnstert.2018.07.051
    UR  - https://doi.org/10.1016/j.fertnstert.2018.07.051
    ER  - 
    

2017

  1. Glimelius I, Eloranta S, Ekberg S, Chang ET, Neovius M, Smedby KE. Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy. American Journal of Hematology 2017;92(3):251-258. View →
    Cite
    @article{glimelius2017,
      author  = {Glimelius, I. and Eloranta, S. and Ekberg, S. and Chang, E. T. and Neovius, M. and Smedby, K. E.},
      title   = {{Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy}},
      journal = {American Journal of Hematology},
      year    = {2017},
      volume  = {92},
      number  = {3},
      pages   = {251--258},
      doi     = {10.1002/ajh.24623}
    }
    
    TY  - JOUR
    AU  - Glimelius, I.
    AU  - Eloranta, S.
    AU  - Ekberg, S.
    AU  - Chang, E. T.
    AU  - Neovius, M.
    AU  - Smedby, K. E.
    TI  - Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy
    JO  - American Journal of Hematology
    PY  - 2017
    VL  - 92
    IS  - 3
    SP  - 251
    EP  - 258
    DO  - 10.1002/ajh.24623
    UR  - https://doi.org/10.1002/ajh.24623
    ER  - 
    
  2. Frisk G, Tinge B, Ekberg S, Eloranta S, Bäcklund LM, Lidbrink E, Smedby KE. Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy. Breast Cancer Research and Treatments 2017;166(3):887-896. View →
    Cite
    @article{frisk2017,
      author  = {Frisk, G. and Tinge, B. and Ekberg, S. and Eloranta, S. and Bäcklund, L. M. and Lidbrink, E. and Smedby, K. E.},
      title   = {{Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy}},
      journal = {Breast Cancer Research and Treatments},
      year    = {2017},
      volume  = {166},
      number  = {3},
      pages   = {887--896},
      doi     = {10.1007/s10549-017-4466-3}
    }
    
    TY  - JOUR
    AU  - Frisk, G.
    AU  - Tinge, B.
    AU  - Ekberg, S.
    AU  - Eloranta, S.
    AU  - Bäcklund, L. M.
    AU  - Lidbrink, E.
    AU  - Smedby, K. E.
    TI  - Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy
    JO  - Breast Cancer Research and Treatments
    PY  - 2017
    VL  - 166
    IS  - 3
    SP  - 887
    EP  - 896
    DO  - 10.1007/s10549-017-4466-3
    UR  - https://doi.org/10.1007/s10549-017-4466-3
    ER  - 
    

2016

  1. Everhov ÅH, Ekberg S, Hirschberg AL, Bergmark K, Rådestad AF, Glimelius I, Smedby KE. Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapse. Journal of Cancer Survivorship 2016;10(3):514-23. View →
    Cite
    @article{everhovah2016,
      author  = {{Everhov ÅH} and Ekberg, S. and Hirschberg, A. L. and Bergmark, K. and Rådestad, A. F. and Glimelius, I. and Smedby, K. E.},
      title   = {{Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapse}},
      journal = {Journal of Cancer Survivorship},
      year    = {2016},
      volume  = {10},
      number  = {3},
      pages   = {514--23},
      doi     = {10.1007/s11764-015-0496-1}
    }
    
    TY  - JOUR
    AU  - Everhov ÅH
    AU  - Ekberg, S.
    AU  - Hirschberg, A. L.
    AU  - Bergmark, K.
    AU  - Rådestad, A. F.
    AU  - Glimelius, I.
    AU  - Smedby, K. E.
    TI  - Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapse
    JO  - Journal of Cancer Survivorship
    PY  - 2016
    VL  - 10
    IS  - 3
    SP  - 514
    EP  - 23
    DO  - 10.1007/s11764-015-0496-1
    UR  - https://doi.org/10.1007/s11764-015-0496-1
    ER  - 
    
  2. Chen L, Glimelius I, Neovius M, Ekberg S, Martling A, Eloranta S, Smedby KE. Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss. Cancer Epidemiology, Biomarkers & Prevention 2016;25(6):987-94. View →
    Cite
    @article{chen2016,
      author  = {Chen, L. and Glimelius, I. and Neovius, M. and Ekberg, S. and Martling, A. and Eloranta, S. and Smedby, K. E.},
      title   = {{Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss}},
      journal = {Cancer Epidemiology, Biomarkers \& Prevention},
      year    = {2016},
      volume  = {25},
      number  = {6},
      pages   = {987--94},
      doi     = {10.1158/1055-9965.epi-16-0112}
    }
    
    TY  - JOUR
    AU  - Chen, L.
    AU  - Glimelius, I.
    AU  - Neovius, M.
    AU  - Ekberg, S.
    AU  - Martling, A.
    AU  - Eloranta, S.
    AU  - Smedby, K. E.
    TI  - Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss
    JO  - Cancer Epidemiology, Biomarkers & Prevention
    PY  - 2016
    VL  - 25
    IS  - 6
    SP  - 987
    EP  - 94
    DO  - 10.1158/1055-9965.epi-16-0112
    UR  - https://doi.org/10.1158/1055-9965.epi-16-0112
    ER  - 
    
  3. Simard JF, Ekberg S, Johansson ALV, Askling J. What is the impact of chronic systemic inflammation such as rheumatoid arthritis on mortality following cancer?. Annals of the Rheumatic Diseases 2016;75(5):862-866. View →
    Cite
    @article{simard2016,
      author  = {Simard, J. F. and Ekberg, S. and Johansson, A. L. V. and Askling, J.},
      title   = {{What is the impact of chronic systemic inflammation such as rheumatoid arthritis on mortality following cancer?}},
      journal = {Annals of the Rheumatic Diseases},
      year    = {2016},
      volume  = {75},
      number  = {5},
      pages   = {862--866},
      doi     = {10.1136/annrheumdis-2014-207155}
    }
    
    TY  - JOUR
    AU  - Simard, J. F.
    AU  - Ekberg, S.
    AU  - Johansson, A. L. V.
    AU  - Askling, J.
    TI  - What is the impact of chronic systemic inflammation such as rheumatoid arthritis on mortality following cancer?
    JO  - Annals of the Rheumatic Diseases
    PY  - 2016
    VL  - 75
    IS  - 5
    SP  - 862
    EP  - 866
    DO  - 10.1136/annrheumdis-2014-207155
    UR  - https://doi.org/10.1136/annrheumdis-2014-207155
    ER  - 
    

2015

  1. Glimelius I, Ekberg S, Linderoth J, Jerkeman M, Chang ET, Neovius M, Smedby KE. Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time–a population-based comparative study. Journal of Cancer Survivorship 2015;9(4):599-609. View →
    Cite
    @article{glimelius2015,
      author  = {Glimelius, I. and Ekberg, S. and Linderoth, J. and Jerkeman, M. and Chang, E. T. and Neovius, M. and Smedby, K. E.},
      title   = {{Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study}},
      journal = {Journal of Cancer Survivorship},
      year    = {2015},
      volume  = {9},
      number  = {4},
      pages   = {599--609},
      doi     = {10.1007/s11764-015-0436-0}
    }
    
    TY  - JOUR
    AU  - Glimelius, I.
    AU  - Ekberg, S.
    AU  - Linderoth, J.
    AU  - Jerkeman, M.
    AU  - Chang, E. T.
    AU  - Neovius, M.
    AU  - Smedby, K. E.
    TI  - Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time–a population-based comparative study
    JO  - Journal of Cancer Survivorship
    PY  - 2015
    VL  - 9
    IS  - 4
    SP  - 599
    EP  - 609
    DO  - 10.1007/s11764-015-0436-0
    UR  - https://doi.org/10.1007/s11764-015-0436-0
    ER  - 
    
  2. Glimelius I, Ekberg S, Linderoth J, Jerkeman M, Chang ET, Neovius M, Smedby KE. Erratum to: Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time-a population-based comparative study. Journal of Cancer Survivorship 2015;9(4):610-1. View →
    Cite
    @article{glimelius2015b,
      author  = {Glimelius, I. and Ekberg, S. and Linderoth, J. and Jerkeman, M. and Chang, E. T. and Neovius, M. and Smedby, K. E.},
      title   = {{Erratum to: Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time-a population-based comparative study}},
      journal = {Journal of Cancer Survivorship},
      year    = {2015},
      volume  = {9},
      number  = {4},
      pages   = {610--1},
      doi     = {10.1007/s11764-015-0464-9}
    }
    
    TY  - JOUR
    AU  - Glimelius, I.
    AU  - Ekberg, S.
    AU  - Linderoth, J.
    AU  - Jerkeman, M.
    AU  - Chang, E. T.
    AU  - Neovius, M.
    AU  - Smedby, K. E.
    TI  - Erratum to: Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time-a population-based comparative study
    JO  - Journal of Cancer Survivorship
    PY  - 2015
    VL  - 9
    IS  - 4
    SP  - 610
    EP  - 1
    DO  - 10.1007/s11764-015-0464-9
    UR  - https://doi.org/10.1007/s11764-015-0464-9
    ER  - 
    
  3. Chen L, Glimelius I, Neovius M, Eloranta S, Ekberg S, Martling A, Smedby KE. Risk of disability pension in patients following rectal cancer treatment and surgery. British Journal of Surgery 2015;102(11):1426-32. View →
    Cite
    @article{chen2015,
      author  = {Chen, L. and Glimelius, I. and Neovius, M. and Eloranta, S. and Ekberg, S. and Martling, A. and Smedby, K. E.},
      title   = {{Risk of disability pension in patients following rectal cancer treatment and surgery}},
      journal = {British Journal of Surgery},
      year    = {2015},
      volume  = {102},
      number  = {11},
      pages   = {1426--32},
      doi     = {10.1002/bjs.9885}
    }
    
    TY  - JOUR
    AU  - Chen, L.
    AU  - Glimelius, I.
    AU  - Neovius, M.
    AU  - Eloranta, S.
    AU  - Ekberg, S.
    AU  - Martling, A.
    AU  - Smedby, K. E.
    TI  - Risk of disability pension in patients following rectal cancer treatment and surgery
    JO  - British Journal of Surgery
    PY  - 2015
    VL  - 102
    IS  - 11
    SP  - 1426
    EP  - 32
    DO  - 10.1002/bjs.9885
    UR  - https://doi.org/10.1002/bjs.9885
    ER  - 
    
  4. Glimelius I, Ekberg S, Jerkeman M, Chang ET, Björkholm M, Andersson TM, Smedby KE, Eloranta S. Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics. American Journal of Hematology 2015;90(12):1128-34. View →
    Cite
    @article{glimelius2015c,
      author  = {Glimelius, I. and Ekberg, S. and Jerkeman, M. and Chang, E. T. and Björkholm, M. and Andersson, T. M. and Smedby, K. E. and Eloranta, S.},
      title   = {{Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics}},
      journal = {American Journal of Hematology},
      year    = {2015},
      volume  = {90},
      number  = {12},
      pages   = {1128--34},
      doi     = {10.1002/ajh.24184}
    }
    
    TY  - JOUR
    AU  - Glimelius, I.
    AU  - Ekberg, S.
    AU  - Jerkeman, M.
    AU  - Chang, E. T.
    AU  - Björkholm, M.
    AU  - Andersson, T. M.
    AU  - Smedby, K. E.
    AU  - Eloranta, S.
    TI  - Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics
    JO  - American Journal of Hematology
    PY  - 2015
    VL  - 90
    IS  - 12
    SP  - 1128
    EP  - 34
    DO  - 10.1002/ajh.24184
    UR  - https://doi.org/10.1002/ajh.24184
    ER  - 
    

2012

  1. Ekberg S, Ploner A, de Faire U, Pedersen NL, Bennet AM. Familial effects on survival after myocardial infarction: a registry-based sib-pair study. European Journal of Epidemiology 2012;27(12):911-914. View →
    Cite
    @article{ekberg2012,
      author  = {Ekberg, S. and Ploner, A. and de Faire, U. and Pedersen, N. L. and Bennet, A. M.},
      title   = {{Familial effects on survival after myocardial infarction: a registry-based sib-pair study}},
      journal = {European Journal of Epidemiology},
      year    = {2012},
      volume  = {27},
      number  = {12},
      pages   = {911--914},
      doi     = {10.1007/s10654-012-9741-3}
    }
    
    TY  - JOUR
    AU  - Ekberg, S.
    AU  - Ploner, A.
    AU  - de Faire, U.
    AU  - Pedersen, N. L.
    AU  - Bennet, A. M.
    TI  - Familial effects on survival after myocardial infarction: a registry-based sib-pair study
    JO  - European Journal of Epidemiology
    PY  - 2012
    VL  - 27
    IS  - 12
    SP  - 911
    EP  - 914
    DO  - 10.1007/s10654-012-9741-3
    UR  - https://doi.org/10.1007/s10654-012-9741-3
    ER  - 
    

Work with Sara and the team

Tell us about your project, submission, or training need and we'll connect you with the right expert.

Get in touch Start a project